Thursday, February 21, 2019
Lenvima and Everolimus: The First and Only Combination of a Tyrosine Kinase Inhibitor and a mTOR Inhibitor for the Treatment of Advanced Renal Cell Carcinoma.
Speaker:
Dr. Shaker Dakhil, MD FACP
Cancer Center of Kansas PA, President
Where:
Greystone Steakhouse
9719 E 21stSt.
Wichita, KS 67206
When:
5:30 pm Meet and Greet
6:00 pm Presentation
RSVP:
To register to attend this program, enter program code 60105 at http://rsvp.esi-speakerprograms.com or call (877) 869-2854.
Heather Schulze